Sanofi posts higher sales, lower profit in first quarter
Sanofi, the French pharmaceutical manufacturer, said on Thursday that its first-quarter net income attributable to equity holders fell 43.2% to €1.13 billion ($1.21 billion) from last year's €2 billion. The figures are based on the International Financial Reporting Standards or IFRS. Earnings per share declined 43.1% to €0.91 from €1.60 a year ago. Business net income was €2.22 billion, compared to €2.70 billion last year. Business earnings per share were €1.78, compared to €2.16 last year. IFRS net sales grew 2.4% to €10.46 billion from last year's €10.22 billion. Sales growth was 6.7% at con...